HIV Patients Show Better Immune Recovery With Early Initiation of HAART

This is Archived content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). For current information, please visit nida.nih.gov.

line graph - see caption Among 655 men and women with HIV, CD4+ count at HAART initiation predicted subsequent recovery of this important immune system cell. Patients receiving HAART showed an improvement after 4 years of treatment and maintained these levels for the next two. The researchers note, however, that those who began treatment after their CD4+ levels fell below 350 cells/ul failed to recover to normal levels. To achieve better recovery, the authors suggest HAART therapy be initiated when the CD4+ cell count is greater than 350 cells/ul.

Source

Moore, R.D. and Keruly, J.C. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clinical Infectious Diseases 44(3):441-446, 2007